New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Growth was broad-based across segments
Aims to boost speed & precision in patient care
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals)_256_384.jpg)
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Subscribe To Our Newsletter & Stay Updated
